Signaling Kinectics

Recently there has been an explosion of interest in the kinetics / timing of signaling, enabled by biosensors of signaling. We developed equations to enable you to do curve fitting on the time course data. Plug-in equation libraries for GraphPad Prism are available for free.

Recently there has been an explosion of interest in the kinetics / timing of signaling, enabled by biosensors of signaling that permit continuous recording of the kinetic waveform from a single well.

At Pharmechanics we developed equations to enable you to do curve fitting on the time course waveform data. Plug-in equation libraries for GraphPad Prism are available for free.

For information check out the PDF below. The Prism files and more information can be found here. For a deeper dive, check out the workshop video here from the ASCEPT 2023 meeting. For the theory see the open-access paper here.

This work was supported by Montana Molecular, designers and suppliers of very high quality fluorescent biosensors of signaling. We have worked together to provide solutions for quantifying the kinetics of signaling for numerous laboratories.

Related

Resources

Introduction & User Manual

Signaling Kinetics Analysis

How to perform signaling kinetic analysis in GraphPad Prism

Files

New Time Equation Files

Equations in GraphPad Prism template files

Training video

Youtube Workshop

Tutorial video. For practice files see links in video description

Paper

Open Access Research

Publication describing and reviewing kinetic signaling analysis.

Bio Image

Why Choose Pharmechanics?

Pharmechanics was founded by Dr Sam Hoare in 2017, with the goal of helping pharmacologists analyze, interpret and apply their data to accelerate drug discovery and basic research on drug targets. See testimonials here to see how I can support your science.

Sam is a globally-recognized expert on industrial, applied and theoretical pharmacology. As Lead Pharmacologist at Neurocrine Biosciences, his leadership, experience and insights were instrumental in the pharmacological optimization of three novel FDA-approved therapeutics, and several more compounds in clinical development.

Learn More